BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q9)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 188.87%19.11M | -42.35%16.97M | -63.41%6.61M | -82.78%1.62M | -30.70%29.43M | -6.05%25.29M | 2.66%18.08M | 8.29%9.38M | 0.74%42.47M | -25.05%26.91M |
Operating income | 188.87%19.11M | -42.35%16.97M | -63.41%6.61M | -82.78%1.62M | -30.70%29.43M | -6.05%25.29M | 2.66%18.08M | 8.29%9.38M | 0.74%42.47M | -25.05%26.91M |
Cost of sales | -82.01%-11.94M | 53.97%-15.83M | 58.15%-6.56M | 54.06%-4.97M | 11.13%-34.4M | -7.65%-27.04M | 7.28%-15.67M | -26.33%-10.81M | 16.08%-38.71M | 17.83%-25.12M |
Operating expenses | -82.01%-11.94M | 53.97%-15.83M | 58.15%-6.56M | 54.06%-4.97M | 11.13%-34.4M | -7.65%-27.04M | 7.28%-15.67M | -26.33%-10.81M | 16.08%-38.71M | 17.83%-25.12M |
Gross profit | 12,932.73%7.17M | 122.85%1.14M | -97.71%55K | -134.01%-3.35M | -231.96%-4.97M | -198.16%-1.76M | 241.13%2.41M | -1,490.29%-1.43M | 194.91%3.76M | -66.42%1.79M |
Administrative expenses | -0.08%-3.59M | -4.71%-12.48M | 34.55%-3.59M | 38.77%-2.28M | 0.88%-11.92M | -4.04%-7.72M | 10.32%-5.48M | -23.92%-3.73M | 23.40%-12.02M | 25.64%-7.42M |
Impairment and provision | ---- | 72.32%-3.06M | ---- | ---- | 15.44%-11.04M | ---- | ---- | ---- | -47.48%-13.06M | ---- |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---151K | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | 71.93%-3.06M | ---- | ---- | 16.60%-10.89M | ---- | ---- | ---- | -63.57%-13.06M | ---- |
Special items of operating profit | -99.71%3K | -82.95%251K | 61.65%1.04M | 2,710.81%1.04M | -50.44%1.47M | 1.79%795K | -17.22%644K | -95.19%37K | 14.19%2.97M | -62.43%781K |
Operating profit | 243.66%3.58M | 46.52%-14.15M | -2.42%-2.49M | 10.31%-4.59M | -44.20%-26.45M | -79.15%-8.68M | 47.45%-2.43M | -139.93%-5.12M | 29.21%-18.34M | -89.11%-4.85M |
Financing cost | 85.00%-3K | -0.40%-992K | -100.00%-20K | -300.00%-16K | 55.31%-988K | 98.68%-20K | 97.54%-10K | 98.47%-4K | -20.69%-2.21M | -17.77%-1.52M |
Earning before tax | 242.40%3.58M | 44.83%-15.14M | -2.82%-2.51M | 10.07%-4.61M | -33.49%-27.44M | -36.73%-8.7M | 51.49%-2.44M | -113.86%-5.12M | 25.91%-20.55M | -65.23%-6.36M |
Tax | ---- | ---- | ---- | ---- | 16.45%177K | ---- | ---- | ---- | 108.47%152K | --152K |
After-tax profit from continuing operations | 242.40%3.58M | 44.47%-15.14M | -2.82%-2.51M | 10.07%-4.61M | -33.62%-27.26M | -40.07%-8.7M | 49.98%-2.44M | -113.86%-5.12M | 30.93%-20.4M | -61.28%-6.21M |
Earning after tax | 242.40%3.58M | 44.47%-15.14M | -2.82%-2.51M | 10.07%-4.61M | -33.62%-27.26M | -40.07%-8.7M | 49.98%-2.44M | -113.86%-5.12M | 30.93%-20.4M | -61.28%-6.21M |
Profit attributable to shareholders | 242.40%3.58M | 44.47%-15.14M | -2.82%-2.51M | 10.07%-4.61M | -33.62%-27.26M | -40.07%-8.7M | 49.98%-2.44M | -113.86%-5.12M | 30.93%-20.4M | -61.28%-6.21M |
Basic earnings per share | 218.64%0.0261 | 48.14%-0.1238 | -2.80%-0.022 | 10.24%-0.0403 | -1.92%-0.2387 | -562.61%-0.0762 | -130.11%-0.0214 | -798.00%-0.0449 | 47.28%-0.2342 | -43.75%-0.0115 |
Diluted earnings per share | 218.64%0.0261 | 48.14%-0.1238 | -2.80%-0.022 | 10.24%-0.0403 | -1.92%-0.2387 | -562.61%-0.0762 | -130.11%-0.0214 | -798.00%-0.0449 | 47.28%-0.2342 | -43.75%-0.0115 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | Zhongzhu Global Certified Public Accountants Co., Ltd. | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.